0
ARTICLE |

Hepatitis A Vaccines

David S. Krause, MD
JAMA. 1996;276(6):449. doi:10.1001/jama.1996.03540060025019.
Text Size: A A A
Published online

To the Editor.  —A Medical News & Perspectives article entitled "Changes Ahead in Childhood Immunization"1 mentioned an investigational hepatitis A vaccine manufactured by Merck and Co (Vaqta). In the article, a Merck spokesperson stated that he hopes this vaccine will "translate into a safety advantage" compared with the currently licensed inactivated hepatitis A vaccine (Havrix, SmithKline Beecham Biologicals, Rixensart, Belgium).Havrix appears to be an extraordinarily safe vaccine. In the efficacy trial by Innis et al,2 more than 104 000 doses of Havrix were administered to children and adolescents without the occurrence of a single serious adverse event related to the vaccine.2 This safety record has been confirmed in clinical trials elsewhere.3To date, Havrix is the only licensed vaccine in the United States for the prevention of hepatitis A. No trials have been published comparing the safety of Havrix with that of Vaqta. Given the

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();